Neurogene Inc. Stock Analysis & AI Score
Neurogene Inc. (NGNE) has an ST Score of 48.0 (C+), driven by its Forecast (A) and held back by its Growth (F). Analysts rate it Buy with a $72.00 price target (+183.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AINGNE Stock Price History
NGNE Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
NGNE Latest Stock News
ST Score
Neurogene Inc. (NGNE) has an ST Score of 48.0 (C+), driven by its Forecast (A) and held back by its Growth (F). Analysts rate it Buy with a $72.00 price target (+183.5% upside).
- Strongest
- ForecastA
- Weakest
- GrowthF
All factor grades
- ForecastA
- Financial StrengthB+
- ValuationB
- MomentumB-
- ProfitabilityC+
- GrowthF
- Piotroski1/9
Press Releases
Company Contact Details
NGNE stock: frequently asked questions
What is NGNE's ST Score?
Neurogene Inc. (NGNE) has an ST Score of 48.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NGNE a buy, hold, or sell?
Analysts rate NGNE a Buy, with a price target of $72.00 (+183.5% vs the current price). Our ST Score grades it C+ (48.0/100). The ST Score is a data-driven signal, not a recommendation.
What are NGNE's factor grades?
Valuation B, Profitability C+, Financial Strength B+, Momentum B-, Growth F, Forecast A.
What is NGNE's valuation grade?
Neurogene Inc. (NGNE) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NGNE's growth grade?
Neurogene Inc. (NGNE) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NGNE's profitability grade?
Neurogene Inc. (NGNE) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NGNE's financial strength grade?
Neurogene Inc. (NGNE) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NGNE?
The average analyst price target for Neurogene Inc. (NGNE) is $72.00 from 7 analysts, which is +183.5% versus the recent price of $25.40.
What is NGNE's Piotroski score?
Neurogene Inc. (NGNE) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.